Header Logo

Connection

TETSUO ASHIZAWA to Severity of Illness Index

Back to Details
This is a "connection" page, showing publications TETSUO ASHIZAWA has written about Severity of Illness Index.
TETSUO ASHIZAWA
Connection Strength
0.521
Severity of Illness Index
  1. SARA captures disparate progression and responsiveness in spinocerebellar ataxias. J Neurol. 2024 Jul; 271(7):3743-3753.
    View in: PubMed
    Score: 0.122
  2. Objective home-based gait assessment in spinocerebellar ataxia. J Neurol Sci. 2012 Feb 15; 313(1-2):95-8.
    View in: PubMed
    Score: 0.051
  3. Suicidal Ideation in Spinocerebellar Ataxia. J Neuropsychiatry Clin Neurosci. 2026; 38(1):38-44.
    View in: PubMed
    Score: 0.032
  4. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology. 2005 Apr 12; 64(7):1261-2.
    View in: PubMed
    Score: 0.032
  5. The impact of interrupted ATXN10 expansions on clinical findings of spinocerebellar ataxia type 10. J Neurol. 2025 Mar 11; 272(4):261.
    View in: PubMed
    Score: 0.032
  6. Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of Ataxia. Mov Disord. 2025 May; 40(5):917-927.
    View in: PubMed
    Score: 0.032
  7. Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias. Mov Disord Clin Pract. 2024 May; 11(5):496-503.
    View in: PubMed
    Score: 0.030
  8. Balance and physical functioning in Spinocerebellar ataxias 3 and 10. Acta Neurol Scand. 2021 Apr; 143(4):458-463.
    View in: PubMed
    Score: 0.024
  9. The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2020 03; 72:37-43.
    View in: PubMed
    Score: 0.023
  10. Sensory and motor cortex function contributes to symptom severity in spinocerebellar ataxia type 6. Brain Struct Funct. 2017 03; 222(2):1039-1052.
    View in: PubMed
    Score: 0.018
  11. Emerging therapies in Friedreich's ataxia. Neurodegener Dis Manag. 2016; 6(1):49-65.
    View in: PubMed
    Score: 0.017
  12. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression. Cerebellum. 2015 Dec; 14(6):677-81.
    View in: PubMed
    Score: 0.017
  13. Depression and clinical progression in spinocerebellar ataxias. Parkinsonism Relat Disord. 2016 Jan; 22:87-92.
    View in: PubMed
    Score: 0.017
  14. Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. J Neuroophthalmol. 2015 Mar; 35(1):16-21.
    View in: PubMed
    Score: 0.016
  15. Coenzyme Q10 and spinocerebellar ataxias. Mov Disord. 2015 Feb; 30(2):214-20.
    View in: PubMed
    Score: 0.016
  16. Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. J Child Neurol. 2012 Sep; 27(9):1152-8.
    View in: PubMed
    Score: 0.013
  17. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord. 2010 Mar 15; 25(4):426-32.
    View in: PubMed
    Score: 0.011
  18. Health related quality of life measures in Friedreich Ataxia. J Neurol Sci. 2008 Sep 15; 272(1-2):123-8.
    View in: PubMed
    Score: 0.010
  19. Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology. 2006 Jun 13; 66(11):1711-6.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.